IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Paratek Pharmaceuticals

CUSIP: 699CVR031 | 3 institutional holders

Quarters

Q2 2025Q1 2024Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2025

Churchill Management Corp10,000
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Churchill Management Corp
10,000$00.0%ValueLowLos Angeles, CA2025-07-18